Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Robert E. Weibel"'
Publikováno v:
Pediatrics. 101:383-387
Objective. To determine if there is evidence for a causal relationship between acute encephalopathy followed by permanent brain injury or death associated with the administration of further attenuated measles vaccines (Attenuvax or Lirugen, Hoechst M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcd327ba97cb5ddc4a3be954f638cd5
https://doi.org/10.1542/peds.101.3.383
https://doi.org/10.1542/peds.101.3.383
Publikováno v:
Vaccine. 29(47)
Aims Documentation of clinical-pathological features of 37 infants/children whose parents alleged a relationship between vaccination and death or permanent central nervous system (CNS) damage, and sought compensation through the National Vaccine Inju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50dccdd0bcde6104812504925fd07a9f
https://pubmed.ncbi.nlm.nih.gov/21854821
https://pubmed.ncbi.nlm.nih.gov/21854821
Autor:
David E. Benor, Robert E. Weibel
Publikováno v:
Arthritis and rheumatism. 39(9)
Objective. To report the outcome of 124 claims of chronic arthropathy associated with rubella vaccine submitted to the National Vaccine Injury Compensation Program. Methods. Medical records and testimony were reviewed separately by physicians and Spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6655353d9b03942582f8d8cf28ba0dd
https://pubmed.ncbi.nlm.nih.gov/8814065
https://pubmed.ncbi.nlm.nih.gov/8814065
Autor:
Beverly J. Neff, Barbara A. Watson, Robert E. Weibel, Philip J. Provost, David H. Morton, Holly Matthews, Stanley A. Plotkin, Barbara J. Kuter, Stuart E. Starr, Harry A. Guess
Publikováno v:
Vaccine. 9(9)
A large double-blind, randomized, placebo-controlled trial of live attenuated Oka/Merck varicella vaccine was conducted among healthy children, 1-14 years of age. During the first varicella season, the efficacy of the vaccine among susceptible childr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f103886f329684d657c8ee47578fe6a
https://pubmed.ncbi.nlm.nih.gov/1659052
https://pubmed.ncbi.nlm.nih.gov/1659052
Publikováno v:
Journal of Infection. 1:73-88
Summary It has been shown that polyvalent pneumococcal polysaccharide vaccine, now commercially available, is safe, antigenic, and provides protection against pneumonias caused by the pneumococcal serotypes which are present in the vaccine. Early stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::055b2d504d9fc59ce92d1789a8204e50
https://doi.org/10.1016/s0163-4453(79)80034-1
https://doi.org/10.1016/s0163-4453(79)80034-1
Autor:
Buynak Eb, Robert E. Weibel, William J. McAleer, Victor M. Villarejos, Maurice R. Hilleman, Henry Z. Markus, Arlene A. McLean
Publikováno v:
Journal of Biological Standardization. 10:329-333
A single-dose, low-cost vaccine delivery system (Ezeject®) consisting of lyophilized measles (Moraten—Attenuvax®) vaccine loaded into a pre-filled single-dose plastic syringe with a squeezable body portion has been developed in these laboratories
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1873a664a3ca166e6b24b7ea98cf9b5f
https://doi.org/10.1016/s0092-1157(82)80009-7
https://doi.org/10.1016/s0092-1157(82)80009-7
Publikováno v:
Experimental Biology and Medicine. 165:260-263
Antibody persistence was measured in children in the open community 10.5 years after combined measles-mumps-rubella (14 children), 9 years after measles-rubella (17 children), 10.5 years after mumps-rubella (9 children), and 7 years after measles-mum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec7959852e01b46475cc93be98b98eb
https://doi.org/10.3181/00379727-165-40967
https://doi.org/10.3181/00379727-165-40967
Publikováno v:
Pediatrics. 61:5-11
Hemagglutination-inhibiting antibodies were retained in comparable levels eight years after vaccination with Enders' original Edmonston and more attenuated Moraten (Attenuvax) and Schwarz line measles vaccines. Neutralizing antibody persisted without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a9deed03cb0ba3a071d1fd57e57a0e
https://doi.org/10.1542/peds.61.1.5
https://doi.org/10.1542/peds.61.1.5
Autor:
Wallace L. Davidson, A. F. Woodhour, Arlene A. McLean, Maurice R. Hilleman, Philip P. Vella, Robert E. Weibel
Publikováno v:
Experimental Biology and Medicine. 156:144-150
SummaryClinical studies of 12- and 14-valent pneumococcal capsular polysaccha-ride vaccines were carried out among 76 adults and 42 children. All but a small proportion of persons developed significant increases in homologous antibody against all cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed2bd870e9dae4eba33439d00ad2b6ad
https://doi.org/10.3181/00379727-156-39894
https://doi.org/10.3181/00379727-156-39894
Publikováno v:
Pediatrics. 56:380-387
Antibody in human subjects persisted without substantial decline for 8 years after mumps vaccine (Jeryl Lynn), for 6 years after measles (Attenuvax), for 5½ years after rubella vaccine (HPV-77 duck), for 5 years after measles-mumps-rubella and mumps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::856dfa3cf60fab5ee7b4287c75a393a0
https://doi.org/10.1542/peds.56.3.380
https://doi.org/10.1542/peds.56.3.380